Navegar por autor "Vidal Insua, Yolanda"

A new prognostic score for medical treatment of malignant obstruction

2014- Vieito Villar, María; Candamio Folgar, Sonia; López López, Rafael; Vidal Insua, Yolanda; Barón Duarte, Francisco Javier; [et al.]

Adherence to capecitabine in patients with colorectal or gastric cancer using microelectronic monitoring systems

2015- Candamio Folgar, Sonia; López López, Rafael; Bernárdez Ferrán, Beatriz; Durán Piñeiro, Goretti; Lamas Díaz, María Jesús; [et al.]

Adjuvant chemoradiotherapy with infusional fluorouracil in high-risk adenocarcinoma of the stomach or gastroesophageal junction

2014- Vieito Villar, María; Candamio Folgar, Sonia; López López, Rafael; Vidal Insua, Yolanda; Vázquez Rivera, Francisca; [et al.]

Adjuvant treatment with infusional 5-fluorouracil in high risk adenocarcinoma of the stomach or gastroesophageal junction

2015- Vieito Villar, María; Candamio Folgar, Sonia; López López, Rafael; Vidal Insua, Yolanda; Vázquez Rivera, Francisca; [et al.]

Clinical significance of baseline Pan-Immune-Inflammation Value and its dynamics in metastatic colorectal cancer patients under first-line chemotherapy

2022- Pérez-Martelo, M.; González-García, A.; Vidal Insua, Yolanda; Blanco Freire, Cristina; Brozos Vázquez, Elena María; [et al.]

Explore the role that dmet genotyping platform may play in search of genetic polymorphism associated with severe toxicity

2011- Carracedo Álvarez, Ángel; Candamio Folgar, Sonia; López López, Rafael; Barros Angueira, Francisco; Bernárdez Ferrán, Beatriz; [et al.]

Metastatic and unresectable biliary tract tumors: A single-center retrospective review

2012- Anido Herranz, Urbano; Vieito Villar, María; Candamio Folgar, Sonia; Gallardo Martín , Maria Elena; López López, Rafael; [et al.]

Methylphenidate in the management of asthenia in breast cancer patients treated with docetaxel: Results of a pilot study

2012- Anido Herranz, Urbano; León Mateos, Luis Ángel; Candamio Folgar, Sonia; Gallardo Martín , Maria Elena; López López, Rafael; [et al.]

Noninvasive early detection of colorectal cancer by hypermethylation of the LINC00473 promoter in plasma cell-free DNA

2022- Ruiz Bañobre, Juan; Rodríguez Casanova, Aitor; Costa Fraga, Nicolás; Bao Caamaño, Aida; Alvarez Castro, Ana Maria; [et al.]

Predicting Outcome and Therapy Response in mCRC Patients Using an Indirect Method for CTCs Detection by a Multigene Expression Panel: A Multicentric Prospective Validation Study

2017-06-13- Vidal Insua, Yolanda; De La Cámara Gómez, Juan Cruz; Brozos Vázquez, Elena María; Fernández Montes, Ana; Vázquez Rivera, Francisca; [et al.]

Prognostic factors in stage II colon cancer after radical resection

2014- Vieito Villar, María; Candamio Folgar, Sonia; López López, Rafael; Vidal Insua, Yolanda; Vázquez Rivera, Francisca; [et al.]

Retrospective study of febrile neutropenia

2012- Anido Herranz, Urbano; Vieito Villar, María; León Mateos, Luis Ángel; Candamio Folgar, Sonia; López López, Rafael; [et al.]

The value of genetic polymorphisms to predict toxicity in metastatic colorectal patients with irinotecan-based regimens

2012- Carracedo Álvarez, Ángel; Mosquera Leal, Ana; Candamio Folgar, Sonia; López López, Rafael; Barros Angueira, Francisco; [et al.]

Use of a comprehensive panel of biomarkers to predict response to a fluorouracil-oxaliplatin regimen in patients with metastatic colorectal cancer.

2011- Carracedo Álvarez, Ángel; Gallardo Martín , Maria Elena; López López, Rafael; Barros Angueira, Francisco; Bernárdez Ferrán, Beatriz; [et al.]

Use of a new prognostic score as a tool to optimize medical treatment in malignant bowel obstruction

2014- Vieito Villar, María; Candamio Folgar, Sonia; López López, Rafael; Vidal Insua, Yolanda; Vázquez Rivera, Francisca; [et al.]

Repositorio digital RUNA

A new prognostic score for medical treatment of malignant obstruction ﻿

Adherence to capecitabine in patients with colorectal or gastric cancer using microelectronic monitoring systems ﻿

Adjuvant chemoradiotherapy with infusional fluorouracil in high-risk adenocarcinoma of the stomach or gastroesophageal junction ﻿

Adjuvant treatment with infusional 5-fluorouracil in high risk adenocarcinoma of the stomach or gastroesophageal junction ﻿

Clinical significance of baseline Pan-Immune-Inflammation Value and its dynamics in metastatic colorectal cancer patients under first-line chemotherapy ﻿

Explore the role that dmet genotyping platform may play in search of genetic polymorphism associated with severe toxicity ﻿

Metastatic and unresectable biliary tract tumors: A single-center retrospective review ﻿

Methylphenidate in the management of asthenia in breast cancer patients treated with docetaxel: Results of a pilot study ﻿

Noninvasive early detection of colorectal cancer by hypermethylation of the LINC00473 promoter in plasma cell-free DNA ﻿

Predicting Outcome and Therapy Response in mCRC Patients Using an Indirect Method for CTCs Detection by a Multigene Expression Panel: A Multicentric Prospective Validation Study ﻿

Prognostic factors in stage II colon cancer after radical resection ﻿

Retrospective study of febrile neutropenia ﻿

The value of genetic polymorphisms to predict toxicity in metastatic colorectal patients with irinotecan-based regimens ﻿

Use of a comprehensive panel of biomarkers to predict response to a fluorouracil-oxaliplatin regimen in patients with metastatic colorectal cancer. ﻿

Use of a new prognostic score as a tool to optimize medical treatment in malignant bowel obstruction ﻿

A new prognostic score for medical treatment of malignant obstruction

Adherence to capecitabine in patients with colorectal or gastric cancer using microelectronic monitoring systems

Adjuvant chemoradiotherapy with infusional fluorouracil in high-risk adenocarcinoma of the stomach or gastroesophageal junction

Adjuvant treatment with infusional 5-fluorouracil in high risk adenocarcinoma of the stomach or gastroesophageal junction

Clinical significance of baseline Pan-Immune-Inflammation Value and its dynamics in metastatic colorectal cancer patients under first-line chemotherapy

Explore the role that dmet genotyping platform may play in search of genetic polymorphism associated with severe toxicity

Metastatic and unresectable biliary tract tumors: A single-center retrospective review

Methylphenidate in the management of asthenia in breast cancer patients treated with docetaxel: Results of a pilot study

Noninvasive early detection of colorectal cancer by hypermethylation of the LINC00473 promoter in plasma cell-free DNA

Predicting Outcome and Therapy Response in mCRC Patients Using an Indirect Method for CTCs Detection by a Multigene Expression Panel: A Multicentric Prospective Validation Study

Prognostic factors in stage II colon cancer after radical resection

Retrospective study of febrile neutropenia

The value of genetic polymorphisms to predict toxicity in metastatic colorectal patients with irinotecan-based regimens

Use of a comprehensive panel of biomarkers to predict response to a fluorouracil-oxaliplatin regimen in patients with metastatic colorectal cancer.

Use of a new prognostic score as a tool to optimize medical treatment in malignant bowel obstruction